Mirum Pharmaceuticals (MIRM) Operating Leases: 2020-2025
Historic Operating Leases for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $9.4 million.
- Mirum Pharmaceuticals' Operating Leases fell 5.91% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 5.91%. This contributed to the annual value of $8.0 million for FY2024, which is 1192.06% up from last year.
- Per Mirum Pharmaceuticals' latest filing, its Operating Leases stood at $9.4 million for Q3 2025, which was down 5.71% from $10.0 million recorded in Q2 2025.
- Mirum Pharmaceuticals' 5-year Operating Leases high stood at $10.0 million for Q3 2024, and its period low was $617,000 during Q4 2023.
- In the last 3 years, Mirum Pharmaceuticals' Operating Leases had a median value of $8.0 million in 2024 and averaged $5.4 million.
- Per our database at Business Quant, Mirum Pharmaceuticals' Operating Leases plummeted by 50.91% in 2023 and then soared by 1,192.06% in 2024.
- Quarterly analysis of 5 years shows Mirum Pharmaceuticals' Operating Leases stood at $1.9 million in 2021, then tumbled by 33.95% to $1.3 million in 2022, then crashed by 50.91% to $617,000 in 2023, then spiked by 1,192.06% to $8.0 million in 2024, then declined by 5.91% to $9.4 million in 2025.
- Its Operating Leases was $9.4 million in Q3 2025, compared to $10.0 million in Q2 2025 and $8.6 million in Q1 2025.